BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017; 9(16): 715-732 [PMID: 28652891 DOI: 10.4254/wjh.v9.i16.715]
URL: https://www.wjgnet.com/1948-5182/full/v9/i16/715.htm
Number Citing Articles
1
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the diseaseAnnals of Hepatology 2021; 21: 100212 doi: 10.1016/j.aohep.2020.04.012
2
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcioRevista de Gastroenterología de México 2021; 86(2): 125 doi: 10.1016/j.rgmx.2020.04.007
3
Avica Atri, Stephen A Jiwanmall, Munaf B Nandyal, Dheeraj Kattula, Sandhiya Paravathareddy, Thomas V Paul, Nihal Thomas, Nitin Kapoor. The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern IndiaEuropean Endocrinology 2020; 16(2): 152 doi: 10.17925/EE.2020.16.2.152
4
Yaoxiang Zhu, Ruijue Liu, Zhenglin Shen, Guoqiang Cai. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathwayLife Sciences 2020; 256: 117990 doi: 10.1016/j.lfs.2020.117990
5
Panyavee Pitisuttithum, Wah Kheong Chan, Panida Piyachaturawat, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Jian Gao Fan, Myeong Jun Song, Seung Kew Yoon, Yock Young Dan, Laurentius Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai Sun Wong, Sombat Treeprasertsuk. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA studyBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01240-z
6
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver BiopsiesJournal of Clinical and Experimental Hepatology 2020; 10(3): 245 doi: 10.1016/j.jceh.2019.07.002
7
Bokyeong Ryu, Kyung-Yeon Eo, Ja-Jun Jang, C-Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun-Ho Lee, Young-Mok Jung, Jae-Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata )Journal of Medical Primatology 2018; 47(4): 270 doi: 10.1111/jmp.12347
8
T. Çevik Saldiran, F. Karantay Mutluay, I. Yağci, Y. Yilmaz. Comparison of aerobic and combined aerobic and whole-body vibration training effects on physical fitness in non-alcoholic fatty liver patientsComparative Exercise Physiology 2021; 17(4): 393 doi: 10.3920/CEP200075
9
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic DisordersInternational Journal of Molecular Sciences 2019; 20(19): 4957 doi: 10.3390/ijms20194957
10
Mohammed F. Abuzinadah, Aftab Ahmad. Pharmacological studies on the efficacy of a thymoquinone‐containing novel polyherbal formulation against cisplatin‐induced hepatorenal toxicity in ratsJournal of Food Biochemistry 2020; 44(2) doi: 10.1111/jfbc.13131
11
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor SignalingMetabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
12
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
13
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapyToxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
14
Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo. Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational StudyNutrients 2019; 11(11): 2601 doi: 10.3390/nu11112601
15
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver diseaseComputers in Biology and Medicine 2021; 131: 104243 doi: 10.1016/j.compbiomed.2021.104243
16
Guillermo Rus, Inas H. Faris, Jorge Torres, Antonio Callejas, Juan Melchor. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis?Sensors 2020; 20(8): 2379 doi: 10.3390/s20082379
17
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
18
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
19
Christian S. Alvarez, Andrea A. Florio, Julia Butt, Alvaro Rivera‐Andrade, María F. Kroker‐Lobos, Tim Waterboer, Maria Constanza Camargo, Neal D. Freedman, Barry I. Graubard, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramírez‐Zea, Katherine A. McGlynn. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala Helicobacter 2020; 25(6) doi: 10.1111/hel.12756
20
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
21
Zixiong Zhou, Jing Qi, Chae Woong Lim, Jong-Won Kim, Bumseok Kim. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitroToxicology 2020; 444: 152579 doi: 10.1016/j.tox.2020.152579
22
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević, Tatjana Radosavljević. Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLDMicroscopy and Microanalysis 2020; 26(5): 997 doi: 10.1017/S1431927620024265
23
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsArchives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
24
Cheng‐Cheng Zhao, Xin‐Yue Wu, Huan Yi, Rong Chen, Gang Fan. The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated ReviewChemistry & Biodiversity 2021; 18(7) doi: 10.1002/cbdv.202100033
25
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept StudyEBioMedicine 2019; 39: 461 doi: 10.1016/j.ebiom.2018.11.020
26
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse ModelNutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
27
Reggiani V. Gonçalves, Jamili D.B. Santos, Natanny S. Silva, Etienne Guillocheau, Robson E. Silva, Thaiany G. Souza-Silva, Rafael F. Oliveira, Eliziária C. Santos, Romulo D. Novaes. Trans-fatty acids aggravate anabolic steroid-induced metabolic disturbances and differential gene expression in muscle, pancreas and adipose tissueLife Sciences 2019; 232: 116603 doi: 10.1016/j.lfs.2019.116603
28
Aishwarya Venkatasubramanian, Anand Thiyagaraj, Vairamuthu Subbiah, Solaipriya Solairaja, Sangaran Arumugam, Satish Ramalingam, Sivaramakrishnan Venkatabalasubramanian. Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental modelComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 247: 109061 doi: 10.1016/j.cbpc.2021.109061
29
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J.L. Bakker, Robin P.F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterolJournal of Lipid Research 2019; 60(1): 168 doi: 10.1194/jlr.P088997
30
Rachelle P. Davis, Bas G. J. Surewaard, Madison Turk, Agostina Carestia, Woo-Yong Lee, Björn Petri, Stefan J. Urbanski, Carla S. Coffin, Craig N. Jenne. Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital MicroscopyFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02988
31
Anca Bălănescu, Iustina Stan, Ioana Codreanu, Valentina Comănici, Eugenia Bălănescu, Paul Bălănescu. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional StudyDisease Markers 2019; 2019: 1 doi: 10.1155/2019/9560247
32
Justin D. Schumacher, Grace L. Guo. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 325 doi: 10.1007/164_2019_228
33
Salwa Seddik Hosny, Hanan Mahmoud Ali, Wesam Ahmed Mohammed, Mohamed Hesham El Ghannam. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DMDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1769 doi: 10.1016/j.dsx.2019.04.002
34
Weiping Wei, Yunqian Li, Yongyong Li, Daoyuan Li. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosisJournal of Pharmacological Sciences 2021; 145(4): 327 doi: 10.1016/j.jphs.2020.12.008
35
Maria Rubio-Ruiz, Verónica Guarner-Lans, Agustina Cano-Martínez, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Anel Gamas-Magaña, Vicente Castrejón-Tellez, Concepción Tapia-Cortina, Israel Pérez-Torres. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome RatsMolecules 2019; 24(7): 1297 doi: 10.3390/molecules24071297
36
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD scoreMinerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
37
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese MiceFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
38
O.Ya. Babak, N.M. Zhelezniakova, A.O. Rozhdestvenska . The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertensionShidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019; 2019(2): 18 doi: 10.15407/internalmed2019.02.018
39
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewJournal of Prescribing Practice 2020; 2(4): 200 doi: 10.12968/jprp.2020.2.4.200
40
Katharina L. Hupa, Elmar Jaeckel, Michael P. Manns. Silymarin for Treatment of Nonalcoholic Steatohepatitis–A New Kid on the Block?Clinical Gastroenterology and Hepatology 2017; 15(12): 1863 doi: 10.1016/j.cgh.2017.08.005
41
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary ReportInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/4549614
42
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longaandTrigonella foenum graecum‐enriched nutrient mixture from germinatedMacrotyloma uniflorumandVigna radiateameliorate nonalcoholic fatty liver diseases in ratsJournal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
43
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in MiceInternational Journal of Molecular Sciences 2020; 21(24): 9362 doi: 10.3390/ijms21249362
44
Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in miceNutrition Research 2019; 67: 78 doi: 10.1016/j.nutres.2019.03.008
45
Karilyn E. Sant, Hadley M. Moreau, Larissa M. Williams, Haydee M. Jacobs, Anna M. Bowsher, Jason D. Boisvert, Roxanna M. Smolowitz, Jacob Pantazis, Kate Annunziato, Malina Nguyen, Alicia Timme-Laragy. Embryonic exposures to mono-2-ethylhexyl phthalate induce larval steatosis in zebrafish independent of Nrf2a signalingJournal of Developmental Origins of Health and Disease 2021; 12(1): 132 doi: 10.1017/S2040174420000057
46
Xin Jiang, Fan Zhang, Xueying Ji, Fangyuan Dong, Huiyuan Yu, Mengjuan Xue, Yixuan Qiu, Fan Yang, Xiaona Hu, Zhijun Bao. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signalingCytokine 2021; 142: 155474 doi: 10.1016/j.cyto.2021.155474
47
Fabiana Kurokawa Hasimoto, Fabiane Valentini Francisqueti-Ferron, Mariane Róvero Costa, Marajane Bruno de Souza, Aline Garcia Aun, Flávia Ribeiro Nogueira, Pedro Henrique Rizzi Alves, Giuseppina Pace Pereira Lima, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Igor Otávio Minatel, Fernando Moreto, Mariana Gobbo Braz, Camila Renata Corrêa. Therapeutic effect of Curcuma longa L. on the nonalcoholic fatty liver disease (NAFLD) physiopathology due fructose consumptionNutrire 2020; 45(2) doi: 10.1186/s41110-020-00127-z
48
P. Melendez, M. Whitney, F. Williams, P. Pinedo, D. Manriquez, S.G. Moore, M.C. Lucy, P. Pithua, S.E. Poock. Technical note: Evaluation of fine needle aspiration cytology for the diagnosis of fatty liver in dairy cattleJournal of Dairy Science 2018; 101(5): 4483 doi: 10.3168/jds.2017-13346
49
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, Heather Francis. Bile Acid Receptor Therapeutics Effects on Chronic Liver DiseasesFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00015
50
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
51
Fatemeh Izadi, Amirhosein Farrokhzad, Babak Tamizifar, Mohammad Javad Tarrahi, Mohammad Hassan Entezari. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trialPhytotherapy Research 2021; 35(1): 477 doi: 10.1002/ptr.6826
52
Md. Abdul Hannan, Md. Ataur Rahman, Abdullah Al Mamun Sohag, Md. Jamal Uddin, Raju Dash, Mahmudul Hasan Sikder, Md. Saidur Rahman, Binod Timalsina, Yeasmin Akter Munni, Partha Protim Sarker, Mahboob Alam, Md. Mohibbullah, Md. Nazmul Haque, Israt Jahan, Md. Tahmeed Hossain, Tania Afrin, Md. Mahbubur Rahman, Md. Tahjib-Ul-Arif, Sarmistha Mitra, Diyah Fatimah Oktaviani, Md Kawsar Khan, Ho Jin Choi, Il Soo Moon, Bonglee Kim. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and SafetyNutrients 2021; 13(6): 1784 doi: 10.3390/nu13061784
53
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesJournal of Endocrinological Investigation 2019; 42(9): 1099 doi: 10.1007/s40618-019-01031-8
54
Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang. Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver diseaseJournal of Medical Biochemistry 2021; 40(1): 86 doi: 10.5937/jomb0-24666
55
Eyun Song, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi. Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VIIFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.647459
56
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failurePharmacological Reports 2021;  doi: 10.1007/s43440-021-00290-8
57
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. BIOCHEMICAL AND RADIOLOGICAL CHANGES IN LIVER STEATOSIS FOLLOWING MIFEPRISTONE TREATMENT IN PATIENTS WITH HYPERCORTISOLISMAACE Clinical Case Reports 2021;  doi: 10.1016/j.aace.2021.07.001
58
Daiane T. Oliveira, Adriano B. Chaves-Filho, Marcos Y. Yoshinaga, Nívia Carolina N. Paiva, Cláudia M. Carneiro, Sayuri Miyamoto, William T. Festuccia, Renata Guerra-Sá. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar dietThe Journal of Nutritional Biochemistry 2021; 87: 108519 doi: 10.1016/j.jnutbio.2020.108519
59
Ashley Cast, Meenasri Kumbaji, Amber D'Souza, Katherine Rodriguez, Anita Gupta, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver DiseaseHepatology Communications 2019; 3(8): 1036 doi: 10.1002/hep4.1381
60
Bingqian Wang, Wenna Li, Hezhi Fang, Huaibin Zhou. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysisMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9619
61
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARαBiochemical Journal 2019; 476(2): 385 doi: 10.1042/BCJ20180517
62
Giacinto Libertini, Graziamaria Corbi, Valeria Conti, Olga Shubernetskaya, Nicola Ferrara. Evolutionary Gerontology and GeriatricsAdvances in Studies of Aging and Health 2021; 2: 291 doi: 10.1007/978-3-030-73774-0_7
63
Beyza Bulutoglu, Camilo Rey-Bedón, Young Bok (Abraham) Kang, Safak Mert, Martin L. Yarmush, O. Berk Usta. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonationLab on a Chip 2019; 19(18): 3022 doi: 10.1039/C9LC00354A
64
Naveen Kaushal, Megha Gupta, Era Kulshreshtha. Hempseed (Cannabis sativa) lipid fractions alleviate high-fat diet-induced fatty liver disease through regulation of inflammation and oxidative stressHeliyon 2020; 6(7): e04422 doi: 10.1016/j.heliyon.2020.e04422
65
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
66
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsAmerican Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
67
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitisF1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
68
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trialComplementary Therapies in Medicine 2019; 44: 44 doi: 10.1016/j.ctim.2019.02.020
69
Musaab Ahmed, Mohamed H Ahmed. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemicWorld Journal of Clinical Cases 2021; 9(17): 4133-4142 doi: 10.12998/wjcc.v9.i17.4133
70
Enxiang Zhang, Shutao Yin, Chong Zhao, Lihong Fan, Hongbo Hu. Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicityBiochemical and Biophysical Research Communications 2020; 528(1): 7 doi: 10.1016/j.bbrc.2020.05.072
71
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
72
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese miceRSC Advances 2018; 8(54): 31194 doi: 10.1039/C8RA05915B
73
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
74
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to HumanFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
75
Zain Moosvi, Felix H. Lui, Douglas Nguyen. Liver Diseases2020; : 407 doi: 10.1007/978-3-030-24432-3_35
76
Arunaksharan Narayanankutty. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic DiseasesCurrent Drug Targets 2019; 20(10): 1068 doi: 10.2174/1389450120666190222181506
77
Chris Boesch. Quantitative MR Imaging Is Increasingly Important in Liver DiseaseRadiology 2018; 286(2): 557 doi: 10.1148/radiol.2017172312
78
Pierangelo Torquato, Desirée Bartolini, Danilo Giusepponi, Marta Piroddi, Bartolomeo Sebastiani, Giorgio Saluti, Roberta Galarini, Francesco Galli. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjectsFree Radical Biology and Medicine 2019; 131: 115 doi: 10.1016/j.freeradbiomed.2018.11.036
79
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular CarcinomaCurrent Drug Metabolism 2019; 20(4): 283 doi: 10.2174/1389200220666190308134351
80
Robin H. Isaacson, Juliane I. Beier, Nicholas KH Khoo, Bruce A. Freeman, Zachary Freyberg, Gavin E. Arteel. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphaneThe Journal of Nutritional Biochemistry 2020; 81: 108399 doi: 10.1016/j.jnutbio.2020.108399
81
Veronica A. Mullins, William Bresette, Laurel Johnstone, Brian Hallmark, Floyd H. Chilton. Genomics in Personalized Nutrition: Can You “Eat for Your Genes”?Nutrients 2020; 12(10): 3118 doi: 10.3390/nu12103118
82
Paul F. Lebeau, Jae Hyun Byun, Khrystyna Platko, Melissa E. MacDonald, Samantha V. Poon, Mahi Faiyaz, Nabil G. Seidah, Richard C. Austin. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in miceJournal of Biological Chemistry 2019; 294(23): 9037 doi: 10.1074/jbc.RA119.008094
83
Tahmine Tavakoli, Asghar Zarban, Reyhaneh Hooshyar, Fatemeh Salmani, Hamidreza Tajik. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazoneArchives of Physiology and Biochemistry 2020; : 1 doi: 10.1080/13813455.2020.1784953
84
Xiaofang Zhang, Caoxin Huang, Xuejun Li, Zhaoshui Shangguan, Wenjing Wei, Suhuan Liu, Shuyu Yang, Yijie Liu. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signalingBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01515-5
85
Zahra Koohestani Sini, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohammad Ali Sardar, Sattar Gorgani Firuzjaee. The Effect of Aerobic Continuous Training on Myonectin, Insulin Resistance and Liver Enzymes in Rats with Nonalcoholic Fatty Liver DiseaseAnnals of Applied Sport Science 2020; 8(4): 0 doi: 10.29252/aassjournal.855
86
Jelena Mustra Rakic, Chun Liu, Sudipta Veeramachaneni, Dayong Wu, Ligi Paul, Lynne M. Ausman, Xiang-Dong Wang. Dietary lycopene attenuates cigarette smoke-promoted nonalcoholic steatohepatitis by preventing suppression of antioxidant enzymes in ferretsThe Journal of Nutritional Biochemistry 2021; 91: 108596 doi: 10.1016/j.jnutbio.2021.108596
87
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J. Lamb, Albert de Roos, Frits R. Rosendaal, Renée de Mutsert. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO studyInternational Journal of Obesity 2020; 44(2): 297 doi: 10.1038/s41366-019-0441-x
88
Sadia Ashraf, Nadia Ashraf, Gizem Yilmaz, Romain Harmancey. Crosstalk between beta‐adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high‐fat diet‐fed male micePhysiological Reports 2021; 9(13) doi: 10.14814/phy2.14958
89
Yuhei Mizunoe, Masaki Kobayashi, Ryoma Tagawa, Yoshimi Nakagawa, Hitoshi Shimano, Yoshikazu Higami. Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic SyndromeInternational Journal of Molecular Sciences 2019; 20(15): 3688 doi: 10.3390/ijms20153688
90
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewGastrointestinal Nursing 2020; 18(2): 22 doi: 10.12968/gasn.2020.18.2.22
91
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
92
Saimila Momin, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 253 doi: 10.1007/978-981-15-5471-1_15
93
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
94
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular DiseaseContemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
95
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathwayJournal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
96
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced ImagesJournal of Medical Imaging and Radiation Sciences 2020; 51(1): 137 doi: 10.1016/j.jmir.2019.12.003
97
Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Lin. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese MiceInternational Journal of Molecular Sciences 2021; 22(13): 6680 doi: 10.3390/ijms22136680
98
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the differenceEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
99
Yuchang Li, Liting Chen, Lu Li, Chantal Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito, Lucy Golden-Mason, Hugo R. Rosen, Jeremy J. Wolff, Cristina I. Silvescu, Samuel Garza, Garett Cheung, Tiffany Huang, Jinjiang Fan, Martine Culty, Bangyan Stiles, Kinji Asahina, Vassilios Papadopoulos. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver diseaseiScience 2021; 24(5): 102457 doi: 10.1016/j.isci.2021.102457
100
Getnet Teshome, Sintayehu Ambachew, Alebachew Fasil, Molla Abebe. <p>Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review</p>Hepatic Medicine: Evidence and Research 2020; : 139 doi: 10.2147/HMER.S265631
101
Erenius Toppo, Naif Abdullah Al-Dhabi, Chinnakulandai Sankar, Sanmugapriya Nagul Kumar, Kanniappan Buvanesvaragurunathan, Santhanam Sylvester Darvin, Antony Stalin, Kedeke Balakrishna, Stanislaus Antony Ceasar, Perumal Pandikumar, Savarimuthu Ignacimuthu, Kuppusamy Sivasankaran, Paul Agastian. Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed ratsEuropean Journal of Pharmacology 2021; 899: 174056 doi: 10.1016/j.ejphar.2021.174056
102
Charlotte D’Mello, Mark G. Swain. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes2021; : 205 doi: 10.1016/B978-0-12-821927-0.00007-3
103
Faisal M Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle EastWorld Journal of Gastroenterology 2020; 26(25): 3528-3541 doi: 10.3748/wjg.v26.i25.3528
104
Chang Li, Jing Ye, Yun Peng, Weiqiang Dou, Songan Shang, Jingtao Wu, Ramin Jafari, Kelly McCabe Gillen, Yi Wang, Martin Prince, Xianfu Luo. Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit modelMagnetic Resonance Imaging 2019; 63: 267 doi: 10.1016/j.mri.2019.08.032
105
Ângela Fernandes, Ana M. Dias, Mariana C. Silva, Joana Gaifem, Catarina M. Azevedo, Iago Carballo, Salomé S. Pinho. Comprehensive Glycoscience2021; : 444 doi: 10.1016/B978-0-12-819475-1.00036-5
106
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep ApneaFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
107
Xiaoyan Hao, Cong Ma, Tianyuan Xiang, Lei Ou, Qiang Zeng. Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese PopulationFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.568398
108
Di-Shuang Hu, Sheng-Hao Zhu, Xu Li, Qin-Fen Chen, Chun-Jing Lin, Dan-Hong Fang, Jian-Sheng Wu. Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic IndividualsCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8748459
109
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid SupplementationNutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
110
Cristina Carvalho, Paula I. Moreira. Obesity and Diabetes2020; : 399 doi: 10.1007/978-3-030-53370-0_29
111
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and AdolescentsFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
112
Marco Raffaele, Lars Bellner, Shailendra P. Singh, Gaia Favero, Rita Rezzani, Luigi Fabrizio Rodella, John R. Falck, Nader G. Abraham, Luca Vanella. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signalingExperimental Cell Research 2019; 380(2): 180 doi: 10.1016/j.yexcr.2019.04.029
113
Arne Janssen, Diederick E Grobbee, Paul Dendale. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular diseaseEuropean Journal of Preventive Cardiology 2020; 27(10): 1059 doi: 10.1177/2047487319891783
114
Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromesDiabetes mellitus 2018; 20(6): 449 doi: 10.14341/DM9374
115
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseasesAdvanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
116
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric populationAnnals of Hepatology 2019; 18(5): 693 doi: 10.1016/j.aohep.2019.04.012
117
Mohamed Mostafa, Amrou Abdelkader, John J. Evans, Catherine E. Hagen, Christopher P. Hartley. Fatty Liver Disease: A Practical ApproachArchives of Pathology & Laboratory Medicine 2020; 144(1): 62 doi: 10.5858/arpa.2019-0341-RA
118
Zuo-Di Fu, Xiao-Ling Cai, Wen-Jia Yang, Ming-Ming Zhao, Ran Li, Yu-Feng Li. Novel glucose-lowering drugs for non-alcoholic fatty liver diseaseWorld Journal of Diabetes 2021; 12(1): 84-97 doi: 10.4239/wjd.v12.i1.84
119
Emma Wilkinson, Yan-Hong Cui, Yu-Ying He. Context-Dependent Roles of RNA Modifications in Stress Responses and DiseasesInternational Journal of Molecular Sciences 2021; 22(4): 1949 doi: 10.3390/ijms22041949
120
Selin Gencer, Yvonne Döring, Yvonne Jansen, Soyolmaa Bayasgalan, Olga Schengel, Madeleine Müller, Linsey J. F. Peters, Christian Weber, Emiel P. C. van der Vorst. Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose TissueBiomedicines 2021; 9(4): 394 doi: 10.3390/biomedicines9040394
121
Carolyne Pimentel Rosado, Victor Hugo Cordeiro Rosa, Bruna Cadete Martins, Aruanna Cajaty Soares, Izabelle Barcellos Santos, Elisa Bernardes Monteiro, Nathália Moura-Nunes, Cristiane Aguiar da Costa, Alessandra da Rocha Pinheiro Mulder, Julio Beltrame Daleprane. Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in miceInternational Journal of Biological Macromolecules 2020; 145: 1066 doi: 10.1016/j.ijbiomac.2019.09.199
122
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
123
Elizabeth J. Millings, Maria Caterina De Rosa, Sarah Fleet, Kazuhisa Watanabe, Richard Rausch, Dieter Egli, Gen Li, Charles A. Leduc, Yiying Zhang, Stuart G. Fischer, Rudolph L. Leibel, Leonidas G. Koniaris. ILDR2 has a negligible role in hepatic steatosisPLOS ONE 2018; 13(5): e0197548 doi: 10.1371/journal.pone.0197548
124
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
125
Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver diseaseAtherosclerosis 2018; 277: 21 doi: 10.1016/j.atherosclerosis.2018.07.028
126
Emir Tas, Shasha Bai, Xiawei Ou, Kelly Mercer, Haixia Lin, Kori Mansfield, Robert Buchmann, Eva C. Diaz, Jon Oden, Elisabet Børsheim, Sean H. Adams, Jonathan Dranoff. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With ObesityFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00654
127
Francesca Oppedisano, Carolina Muscoli, Vincenzo Musolino, Cristina Carresi, Roberta Macrì, Caterina Giancotta, Francesca Bosco, Jessica Maiuolo, Federica Scarano, Sara Paone, Saverio Nucera, Maria Caterina Zito, Miriam Scicchitano, Stefano Ruga, Monica Ragusa, Ernesto Palma, Annamaria Tavernese, Rocco Mollace, Ezio Bombardelli, Vincenzo Mollace. The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter SubfamilyNutrients 2020; 12(5): 1435 doi: 10.3390/nu12051435
128
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
129
Rasoul Shafiezadeh, Seyed Moayed Alavian, Hasan Namdar, Mohammad Gholami-Fesharaki, Seyed Saeid Esmaeili. Evaluating the Efficacy of Carum Copticum Seeds on the Treatment of Patients with Nonalcoholic Fatty Liver Disease: A Multi-Center, Randomized, Triple–Blind, Placebo-Controlled Clinical Trial StudyHepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.110488
130
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut MicrobiotaEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/5378961
131
Ernesto Cortes, Dariusz Lachowski, Alistair Rice, Antonios Chronopoulos, Benjamin Robinson, Stephen Thorpe, David A Lee, Lucia A Possamai, Haiyun Wang, David J Pinato, Armando E. del Río Hernández. Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate CellsHepatology 2019; 69(2): 785 doi: 10.1002/hep.30193
132
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
133
Samira Kazemi, Farzad Shidfar, Simin Ehsani, Peyman Adibi, Leila Janani, Omid Eslami. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trialComplementary Therapies in Clinical Practice 2020; 41: 101259 doi: 10.1016/j.ctcp.2020.101259
134
S. Maâlej, S. Jedidi, H. Hannachi, H. Gharsalli, I. Sahnoun, H. Neji, L. El Gharbi. Prévalence et facteurs de risque de stéatose hépatique chez les adultes tunisiens atteints de syndrome d’apnées hypopnées obstructives du sommeilRevue des Maladies Respiratoires 2020; 37(1): 8 doi: 10.1016/j.rmr.2019.11.643
135
Han Wang, Yanjun Jia, Xiaoyan Yu, Li Peng, Chunfeng Mou, Zhixin Song, Dapeng Chen, Xiaoqiang Li, Antonio Molina Carballo. Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin ResistanceInternational Journal of Endocrinology 2021; 2021: 1 doi: 10.1155/2021/6630102
136
Esteban Porrini, Maruja Navarro-Díaz, Rosa Rodríguez-Rodríguez, Eduardo Salido. Diabetic Nephropathy2019; : 65 doi: 10.1007/978-3-319-93521-8_5
137
Yoosoo Chang, Jin-Won Noh, Joo Young Cheon, Yejin Kim, Young Dae Kwon, Seungho Ryu. Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60823-8
138
Avner Ehrlich, Sabina Tsytkin-Kirschenzweig, Konstantinos Ioannidis, Muneef Ayyash, Anne Riu, Reine Note, Gladys Ouedraogo, Jan Vanfleteren, Merav Cohen, Yaakov Nahmias. Microphysiological flux balance platform unravels the dynamics of drug induced steatosisLab on a Chip 2018; 18(17): 2510 doi: 10.1039/C8LC00357B
139
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenInternational Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
140
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver diseaseMedicine 2021; 100(22): e25817 doi: 10.1097/MD.0000000000025817
141
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosisWorld Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
142
Damien Viglino, Anais Plazanet, Sebastien Bailly, Meriem Benmerad, Ingrid Jullian-Desayes, Renaud Tamisier, Vincent Leroy, Jean-Pierre Zarski, Maxime Maignan, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34988-2
143
Isabel Hidalgo, Nayelli Nájera, Eduardo Meaney, Javier Pérez-Durán, Yolotzin Valdespino-Vazquez, Francisco Villarreal, Guillermo Ceballos. Effects of (−)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitisThe Journal of Nutritional Biochemistry 2020; 77: 108296 doi: 10.1016/j.jnutbio.2019.108296
144
Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic InflammationMarine Drugs 2019; 17(9): 486 doi: 10.3390/md17090486
145
Patrick C. Turnbull, Ali C. Dehghani, Christopher F. Theriau, Michael K. Connor, Christopher G. R. Perry. Synergistic activation of mitochondrial metabolism and the glutathione redox couple protects HepG2 hepatocarcinoma cells from palmitoylcarnitine-induced stressAmerican Journal of Physiology-Cell Physiology 2019; 317(6): C1324 doi: 10.1152/ajpcell.00366.2019
146
Yong Du, Laura Paglicawan, Sanam Soomro, Omar Abunofal, Sahar Baig, Kamala Vanarsa, John Hicks, Chandra Mohan. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage PolarizationNutrients 2021; 13(2): 599 doi: 10.3390/nu13020599
147
Ludivine Renaud, Willian A. da Silveira, E. Starr Hazard, Jonathan Simpson, Silvia Falcinelli, Dongjun Chung, Oliana Carnevali, Gary Hardiman. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNomeGenes 2017; 8(10): 269 doi: 10.3390/genes8100269
148
Prabhakar Yellanur Konda, Vijayakumar Poondla, Krishna Kumar Jaiswal, Sreenivasulu Dasari, Reddemma Uyyala, Venkata Prasad Surtineni, Janardhan Yadav Egi, Anthony Johnson Antony Masilamani, Lakshmi Bestha, Sreenath Konanki, Muthukumaran Muthulingam, Lakshman Kumar Lingamgunta, Bindu Prasuna Aloor, Sridevi Tirumalaraju, Ankanna Sade, Venkata Ratnam Kamsala, Sreeharsha Nagaraja, Ranjani Ramakrishnan, Vijayakumar Natesan. Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73670-4
149
Kannan Sridharan, Gowri Sivaramakrishnan, Reginald Paul Sequeira, Abdelaziz Elamin. Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisPostgraduate Medical Journal 2018; 94(1116): 556 doi: 10.1136/postgradmedj-2018-135967
150
Arya M. Sharma. Differential indications for weight lossCurrent Opinion in Endocrine and Metabolic Research 2019; 4: 58 doi: 10.1016/j.coemr.2018.09.001
151
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese RatsAntioxidants 2019; 8(8): 276 doi: 10.3390/antiox8080276
152
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseasesPhytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
153
Dragana Rajcic, Anja Baumann, Angélica Hernández-Arriaga, Annette Brandt, Anika Nier, Cheng Jun Jin, Victor Sánchez, Finn Jung, Amélia Camarinha-Silva, Ina Bergheim. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginaseRedox Biology 2021; 41: 101879 doi: 10.1016/j.redox.2021.101879
154
N.A. Rajesh, L. Drishya, Murali Mohan Raju Ambati, Athi L. Narayanan, Maria Alex, Kiran Kumar R, Justin J. Abraham, T.M. Vijayakumar. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot StudyJournal of Clinical and Experimental Hepatology 2021;  doi: 10.1016/j.jceh.2021.03.012
155
Angelique M. L. Scantlebery, Peter Ochodnicky, Lotte Kors, Elena Rampanelli, Loes M. Butter, Chaima El Boumashouli, Nike Claessen, Gwen J. Teske, Marius A. van den Bergh Weerman, Jaklien C. Leemans, Joris J. T. H. Roelofs, Sandrine Florquin. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effectScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53890-z
156
Letícia Fernandes Gomes, Sibelle Aparecida Madureira Costa, Arthur Rocha-Gomes, Amanda Escobar Teixeira, Alexandre Alves da Silva, Mayara Rodrigues Lessa, Nísia Andrade Villela Dessimoni-Pinto, Sergio Ricardo Stuckert Seixas, Tania Regina Riul. Cafeteria diet from birth to adulthood promotes hepatic steatosis and redox imbalance in Wistar ratsNutrition & Food Science 2021; 51(3): 483 doi: 10.1108/NFS-05-2020-0191
157
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón. Silymarin is an ally against insulin resistance: A reviewAnnals of Hepatology 2021; 23: 100255 doi: 10.1016/j.aohep.2020.08.072
158
Daiane Costa dos Santos, Josemar Gonçalves de Oliveira Filho, Tainara Leal de Sousa, Carolina Barbosa Ribeiro, Mariana Buranelo Egea. Ameliorating effects of metabolic syndrome with the consumption of rich-bioactive compounds fruits from Brazilian Cerrado: a narrative reviewCritical Reviews in Food Science and Nutrition 2021; : 1 doi: 10.1080/10408398.2021.1916430
159
D.H. Seo, Y.-h. Lee, S.W. Park, Y.J. Choi, B.W. Huh, E. Lee, K.B. Huh, S.H. Kim, B.-S. Cha. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesDiabetes & Metabolism 2020; 46(5): 362 doi: 10.1016/j.diabet.2019.10.004
160
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(2): 314 doi: 10.3390/jcm9020314
161
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityPediatric Research 2019; 85(5): 671 doi: 10.1038/s41390-019-0303-1
162
Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau, Stéphane Bertani. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South AmericaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28286-0
163
Maysa Ahmed Mobasher, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in RatsReports of Biochemistry and Molecular Biology 2020; 9(1): 115 doi: 10.29252/rbmb.9.1.115
164
Matteo Tardelli, Francesca V. Bruschi, Thierry Claudel, Claudia D. Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Gernot F. Grabner, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionJournal of Lipid Research 2019; 60(7): 1284 doi: 10.1194/jlr.M093369
165
Jovana Milic, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVAIDS 2020; 34(13): 1915 doi: 10.1097/QAD.0000000000002650
166
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatmentExpert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
167
Jiayun Ge, Yannan Bai, Bo Tang, Dong Wei, Maolin Yan, Amir Radfar. The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6630535
168
SHIKHA SRIVASTAVA, ZEBA SIDDIQI, TARUNA SINGH, LAKSHMI BALA. Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease PatientsCurrent Research in Nutrition and Food Science Journal 2019; 7(1): 96 doi: 10.12944/CRNFSJ.7.1.10
169
Daniela Maria Tanase, Evelina Maria Gosav, Claudia Florida Costea, Manuela Ciocoiu, Cristina Mihaela Lacatusu, Minela Aida Maranduca, Anca Ouatu, Mariana Floria. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/3920196
170
Fernanda Torres Quitete, Giulia Medeiros Almeida Santos, Leilson de Oliveira Ribeiro, Cristiane Aguiar da Costa, Suely Pereira Freitas, Virgínia Martins da Matta, Julio Beltrame Daleprane. Phenolic-rich smoothie consumption ameliorates non-alcoholic fatty liver disease in obesity mice by increasing antioxidant responseChemico-Biological Interactions 2021; 336: 109369 doi: 10.1016/j.cbi.2021.109369
171
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesityJournal of Pediatric Endocrinology and Metabolism 2020; 33(2): 205 doi: 10.1515/jpem-2019-0204
172
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse ModelsUltrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
173
Luigi Aloia. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After InjuryFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.643055
174
Siavash Mehdizadeh Seraj, Abdullah Al-Zaghal, Mahdi Z. Zadeh, Pegah Jahangiri, Kamyar Pournazari, William Y. Raynor, Thomas J. Werner, Poul F. Høilund-Carlsen, Abass Alavi, Stephen J. Hunt. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMINuclear Medicine Communications 2019; 40(5): 545 doi: 10.1097/MNM.0000000000001000
175
Chih‐Yuan Ko, Yangming Martin Lo, Jian‐Hua Xu, Wen‐Chang Chang, Da‐Wei Huang, James Swi‐Bea Wu, Cho‐Hua Yang, Wen‐Chung Huang, Szu‐Chuan Shen. Alpha‐lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic ratsFood Science & Nutrition 2021; 9(5): 2733 doi: 10.1002/fsn3.2235
176
Annalisa Curcio, Adriana Romano, Simona Cuozzo, Antonio Di Nicola, Orazio Grassi, Donatella Schiaroli, Giuseppe Fabrizio Nocera, Michele Pironti. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD PatientsMedicina 2020; 56(10): 544 doi: 10.3390/medicina56100544
177
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytesJournal of Cellular Physiology 2020; 235(2): 880 doi: 10.1002/jcp.29002
178
Julie Rask Larsen, Lorena Dima, Christoph U. Correll, Peter Manu. The pharmacological management of metabolic syndromeExpert Review of Clinical Pharmacology 2018; 11(4): 397 doi: 10.1080/17512433.2018.1429910
179
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytesPLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
180
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and DiagnosisBiomedicines 2021; 9(2): 145 doi: 10.3390/biomedicines9020145
181
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐upHepatology 2020; 72(2): 430 doi: 10.1002/hep.31040
182
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean PopulationInternational Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
183
Ning Zhang, Yuli Wang, Junli Zhang, Beibei Liu, Guixin Li, Shengliang Xin, Keshu Xu. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in miceMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10316
184
Luo Yang, Xiang Zhang, Min Liao, Yarong Hao. Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db miceLife Sciences 2021; 271: 119237 doi: 10.1016/j.lfs.2021.119237
185
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J Lamb, Albert de Roos, Frits R Rosendaal, Renée de Mutsert. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and WomenThe Journal of Nutrition 2019; 149(2): 304 doi: 10.1093/jn/nxy260
186
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Bioactive Molecules in FoodReference Series in Phytochemistry 2019; : 295 doi: 10.1007/978-3-319-78030-6_57
187
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-ChipCell Reports 2021; 36(3): 109393 doi: 10.1016/j.celrep.2021.109393
188
Katherine Rodriguez, Ashley Cast, Nikolai A. Timchenko. Correction of aging phenotype in the liverAging 2018; 10(8): 1795 doi: 10.18632/aging.101523
189
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 SuppressionHepatology 2019; 69(5): 1946 doi: 10.1002/hep.30485
190
Siân P Cartland, Nicole Tamer, Manisha S Patil, Belinda A Di Bartolo, Mary M Kavurma. A “Western Diet” promotes symptoms of hepatic steatosis in spontaneously hypertensive ratsInternational Journal of Experimental Pathology 2020; 101(5): 152 doi: 10.1111/iep.12369
191
Cíntia Castro-Correia, Rita Santos-Silva, Marta Pinheiro, Carla Costa, Manuel Fontoura. Metabolic risk factors in adolescent girls with type 1 diabetesJournal of Pediatric Endocrinology and Metabolism 2018; 31(6): 631 doi: 10.1515/jpem-2018-0053
192
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver diseaseIndian Journal of Physiology and Pharmacology 2021; 65: 12 doi: 10.25259/IJPP_406_2020
193
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTSMedical Immunology (Russia) 2019; 21(5): 945 doi: 10.15789/1563-0625-2019-5-945-952
194
Xiaolei Zhang, Xueying Shang, Shi Jin, Zhuoqi Ma, He Wang, Na AO, Jing Yang, Jian Du. Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in ratsArchives of Biochemistry and Biophysics 2021; 705: 108894 doi: 10.1016/j.abb.2021.108894
195
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered viewWorld Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
196
David E. Stec, Darren M. Gordon, Jennifer A. Hipp, Stephen Hong, Zachary L. Mitchell, Natalia R. Franco, J. Walker Robison, Christopher D. Anderson, Donald F. Stec, Terry D. Hinds. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2019; 317(5): R733 doi: 10.1152/ajpregu.00153.2019
197
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2017; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
198
Md Akheruzzaman, Vijay Hegde, Andrew C. Shin, Nikhil V. Dhurandhar. Reducing endogenous insulin is linked with protection against hepatic steatosis in miceNutrition & Diabetes 2020; 10(1) doi: 10.1038/s41387-020-0114-9
199
Tomislav Mašek, Josip Barišić, Vedran Micek, Kristina Starčević. Cafeteria Diet and High-Fructose Rodent Models of NAFLD Differ in the Metabolism of Important PUFA and Palmitoleic Acid without Additional Influence of SexNutrients 2020; 12(11): 3339 doi: 10.3390/nu12113339
200
Sok Kuan Wong, Kok-Yong Chin, Fairus Ahmad, Soelaiman Ima-Nirwana. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver diseaseJournal of Functional Foods 2020; 74: 104209 doi: 10.1016/j.jff.2020.104209
201
Bo Wang, Yanghua Qu, Yiping Wang, Yong Ma, Chenchen Xu, Fadi Li, Ce Liu, Xiaonan Lu, Bo Wang, Peng Xiu, Yuefeng Gao, Zhicheng Diao, Yuxia Li, Hailing Luo. Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty LiverThe Journal of Nutrition 2019; 149(6): 989 doi: 10.1093/jn/nxz039
202
Adryana Cordeiro, Raquel Costa, Nelson Andrade, Cláudia Silva, Natalia Canabrava, Maria João Pena, Ilda Rodrigues, Sara Andrade, Andrea Ramalho. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 394 doi: 10.1016/j.clinre.2019.10.001
203
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trialTURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 354 doi: 10.3906/sag-1907-82
204
P. Vineeth Daniel, Surbhi Dogra, Priya Rawat, Abhinav Choubey, Aiysha Siddiq Khan, Sangam Rajak, Mohan Kamthan, Prosenjit Mondal. NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate dietJournal of Biological Chemistry 2021; 296: 100714 doi: 10.1016/j.jbc.2021.100714
205
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
206
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND StudyPLOS ONE 2019; 14(8): e0220659 doi: 10.1371/journal.pone.0220659
207
Ilona Darlyuk-Saadon, Chen Bai, Chew Kiat Matthew Heng, Nechama Gilad, Wei-Ping Yu, Pei Yen Lim, Amaury Cazenave-Gassiot, Yongliang Zhang, W. S. Fred Wong, David Engelberg. Active p38α causes macrovesicular fatty liver in miceProceedings of the National Academy of Sciences 2021; 118(14): e2018069118 doi: 10.1073/pnas.2018069118
208
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride ContentUltrasound in Medicine & Biology 2021; 47(4): 1067 doi: 10.1016/j.ultrasmedbio.2020.12.014
209
Muhammad Amir, Michael Yu, Peijian He, Shanthi Srinivasan. Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00062
210
Resham Ramkissoon, Timothy B. Gardner. Pancreatic Steatosis: An Emerging Clinical EntityAmerican Journal of Gastroenterology 2019; 114(11): 1726 doi: 10.14309/ajg.0000000000000262
211
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, Marialuisa Sponziello, Laura D’Erasmo, Licia Polimeni, Francesco Baratta, Daniele Pastori, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Giuseppe Giannini, Maria Del Ben, Francesco Angelico, Marcello Arca. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21939-0
212
Venkat R. Pannala, Shanea K. Estes, Mohsin Rahim, Irina Trenary, Tracy P. O’Brien, Chiyo Shiota, Richard L. Printz, Jaques Reifman, Masakazu Shiota, Jamey D. Young, Anders Wallqvist. Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in RatsInternational Journal of Molecular Sciences 2020; 21(21): 8250 doi: 10.3390/ijms21218250
213
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
214
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNutrients 2020; 12(5): 1260 doi: 10.3390/nu12051260
215
Maria Kalogirou, Emmanouil Sinakos. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?World Journal of Hepatology 2018; 10(11): 790-794 doi: 10.4254/wjh.v10.i11.790
216
Anirudh Kohli. Is it important to quantify hepatic fibrosis?Indian Journal of Radiology and Imaging 2019; 29(04): 341 doi: 10.4103/ijri.IJRI_521_19
217
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 InhibitionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
218
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
219
Gonçalo Martins Pereira, Sofia S. Pereira, Madalena Santos, José Brito, Diamantino Freitas, António Oliveira de Carvalho, Artur Águas, Maria João Oliveira, Pedro Oliveira. Effects of high-intensity infrasound on liver lipid content of ratsHeliyon 2020; 6(7): e04383 doi: 10.1016/j.heliyon.2020.e04383
220
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
221
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLDJournal of Clinical Medicine 2020; 9(3): 870 doi: 10.3390/jcm9030870
222
Simone Carotti, Katia Aquilano, Francesco Valentini, Sergio Ruggiero, Francesca Alletto, Sergio Morini, Antonio Picardi, Raffaele Antonelli-Incalzi, Daniele Lettieri-Barbato, Umberto Vespasiani-Gentilucci. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(4): G469 doi: 10.1152/ajpgi.00049.2020
223
Wen-Chung Huang, Ya-Ling Chen, Hui-Chia Liu, Shu-Ju Wu, Chian-Jiun Liou. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cellsSaudi Pharmaceutical Journal 2018; 26(8): 1178 doi: 10.1016/j.jsps.2018.07.006
224
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver DiseaseMetabolites 2020; 10(7): 283 doi: 10.3390/metabo10070283
225
Mark G. Swain, David E. J. Jones. Fatigue in chronic liver disease: New insights and therapeutic approachesLiver International 2019; 39(1): 6 doi: 10.1111/liv.13919
226
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver DiseaseAdvances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
227
Helda Tutunchi, Majid Mobasseri, Naser Aghamohammadzadeh, Jalil Hooshyar, Fatemeh Naeini, Farzad Najafipour. Serum neuregulin 4 (NRG‐4) level and non‐alcoholic fatty liver disease (NAFLD): A case‐control studyInternational Journal of Clinical Practice 2021;  doi: 10.1111/ijcp.14555
228
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as ReferenceJournal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
229
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. SweetenersReference Series in Phytochemistry 2018; : 1 doi: 10.1007/978-3-319-54528-8_57-1
230
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese miceCanadian Journal of Physiology and Pharmacology 2019; 97(11): 1018 doi: 10.1139/cjpp-2018-0691
231
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3Life Sciences 2021; 270: 119071 doi: 10.1016/j.lfs.2021.119071
232
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular CarcinomaCells 2020; 9(2): 262 doi: 10.3390/cells9020262
233
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic SyndromeFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
234
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek. Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model Hepatology Communications 2020; 4(1): 109 doi: 10.1002/hep4.1443
235
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination SurveyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7
236
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer CellsAdvanced Healthcare Materials 2019; 8(24): 1901379 doi: 10.1002/adhm.201901379
237
Amir Mohammad Kazemifar, Ali Akbar Shafikhani, Elaheh HajiNoormohammadi, Zahra Azarion, Aliakbar Hajiaghamohammadi. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trialEgyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0001-z
238
S.M. Touhidul Islam, Jeseong Won, Mushfiquddin Khan, Kenneth D. Chavin, Inderjit Singh. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitisAnnals of Hepatology 2020; 19(5): 466 doi: 10.1016/j.aohep.2019.11.007
239
Aurora Barberá, Imma Raurell, Teresa García‐Lezana, Manuel Torres‐Arauz, Miren Bravo, Diana Hide, Mar Gil, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin. Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash modelLiver International 2020; 40(11): 2732 doi: 10.1111/liv.14632
240
Shenzong Rao, Jingsong Huang, Zhijun Shen, Changgang Xiang, Min Zhang, Xueliang Lu. Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver diseaseJournal of Cellular Biochemistry 2019; 120(7): 11867 doi: 10.1002/jcb.28468
241
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
242
M. Bellan, M. Menegatti, C. Ferrari, G.P. Carnevale Schianca, M. Pirisi. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practiceNutrition, Metabolism and Cardiovascular Diseases 2018; 28(6): 610 doi: 10.1016/j.numecd.2018.01.006
243
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar, Guruprasad Padsalgi, Pushpa Mahadevan. Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case seriesIndian Journal of Gastroenterology 2020; 39(1): 97 doi: 10.1007/s12664-020-01028-9
244
Diego Nocetti, Alejandra Espinosa, Francisco Pino-De la Fuente, Camila Sacristán, José Luis Bucarey, Paulina Ruiz, Rodrigo Valenzuela, Raphaël Chouinard-Watkins, Inés Pepper, Rodrigo Troncoso, Luis Puente. Lipid droplets are both highly oxidized and Plin2-covered in hepatocytes of diet-induced obese miceApplied Physiology, Nutrition, and Metabolism 2020; 45(12): 1368 doi: 10.1139/apnm-2019-0966
245
Razk Abdalgwad, Mohammed Faraz Rafey, Conor Murphy, Iulia Ioana, Paula Mary O’Shea, Eoin Slattery, Colin Davenport, Derek Timothy O’Keeffe, Francis Martin Finucane. Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programmeNutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-020-00512-5
246
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Gokhan Zengin, Nicoleta Negrut, Delia Carmen Nistor-Cseppento, Flavia Maria Pavel, Raluca Anca Corb Aron, Simona Bungau. Exploring the Genetic Conception of Obesity via the Dual Role of FoxOInternational Journal of Molecular Sciences 2021; 22(6): 3179 doi: 10.3390/ijms22063179
247
Imran Nazir Salroo, Musharaf Bashir, Rayees Ahmad Bhat, Sheikh Imran Sayeed, Nazir Ahmad Salroo. Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndromeJournal of Clinical Medicine of Kazakhstan 2020; 1(55): 17 doi: 10.23950/1812-2892-JCMK-00732
248
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa RatsNutrients 2021; 13(1): 202 doi: 10.3390/nu13010202
249
Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteriaHPB 2019; 21(12): 1697 doi: 10.1016/j.hpb.2019.04.007
250
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2020; 19(7): 2689 doi: 10.1021/acs.jproteome.9b00405
251
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH2020; : 181 doi: 10.1007/978-3-030-37173-9_10
252
Yi-Hsien Chang, Ya-Ling Chen, Wen-Chung Huang, Chian-Jiun Liou. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathwayBiochemical and Biophysical Research Communications 2018; 495(1): 197 doi: 10.1016/j.bbrc.2017.11.022
253
Igor V. Maev, Alexey A. Samsonov, Leonid B. Lazebnik, Elena V. Golovanova, Chavdar S. Pavlov, Elena I. Vovk, Vlad Ratziu, Kirill M. Starostin. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver DiseaseAdvances in Therapy 2020; 37(11): 4627 doi: 10.1007/s12325-020-01493-w
254
Nikhil Makhija, Naval K. Vikram, Deep N. Srivastava, Kumble S. Madhusudhan. Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance SpectroscopyJournal of Clinical and Experimental Hepatology 2021;  doi: 10.1016/j.jceh.2021.02.008
255
Yue Xiong, Yan Chen, Xinping Huang, Zhen Yang, Jiaye Zhang, Xiaorui Yu, Ji Fang, Jiawang Tao, Kai You, Ziqi Cheng, Shenglin Tan, Yingying Xu, Fang Yuan, Ying Liu, Yuanqi Zhuang, Fan Yang, Yinxiong Li. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivityLife Sciences 2021; 268: 119000 doi: 10.1016/j.lfs.2020.119000
256
Nehal Mohamed Bahgat Gamil, Sahar Mohamed El Agaty, Gehan Khalaf Megahed, Rania Salah Mansour, Marwa Saad Abdel-Latif. Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndromeEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00128-1
257
Hyeon Ju Kim, Yoseob Lee, Sungsoon Fang, Won Kim, Hyo Jung Kim, Jae-woo Kim. GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stressBMB Reports 2020; 53(6): 317 doi: 10.5483/BMBRep.2020.53.6.280
258
Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2018; 48(9): e12988 doi: 10.1111/eci.12988
259
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoidsBiomaterials 2021; 275: 120904 doi: 10.1016/j.biomaterials.2021.120904
260
Jona T. Stahmeyer, Melissa Hemmerling, Birte Burger, Sveja Eberhard, Christian Krauth, Jan Zeidler, Annika Herr, Henning Weseloh, Siegbert Rossol. Die Häufigkeit von diagnostizierten Fettlebererkrankungen (NAFLD) in der deutschen Bevölkerung – Eine Analyse auf der Basis von GKV-RoutinedatenZeitschrift für Gastroenterologie 2021;  doi: 10.1055/a-1402-1263
261
Ayesha Monga Kravetz, Todd Testerman, Brittany Galuppo, Joerg Graf, Bridget Pierpont, Stephan Siebel, Richard Feinn, Nicola Santoro. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese YouthThe Journal of Clinical Endocrinology & Metabolism 2020; 105(10): e3575 doi: 10.1210/clinem/dgaa382
262
Wenqian Xu, Hongkang Zhu, Bin Hu, Yuliang Cheng, Yahui Guo, Weirong Yao, He Qian. Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safetyPhytomedicine 2021; 87: 153572 doi: 10.1016/j.phymed.2021.153572
263
Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in miceLife Sciences 2018; 192: 46 doi: 10.1016/j.lfs.2017.11.027
264
Rose Ghemrawi, Shyue-Fang Battaglia-Hsu, Carole Arnold. Endoplasmic Reticulum Stress in Metabolic DisordersCells 2018; 7(6): 63 doi: 10.3390/cells7060063
265
Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, Han-Jung Chae. Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK ActivationThe American Journal of Chinese Medicine 2019; 47(06): 1253 doi: 10.1142/S0192415X19500642
266
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7781
267
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot studyRevista de Gastroenterología de México (English Edition) 2021; 86(2): 125 doi: 10.1016/j.rgmxen.2020.04.008
268
Sreenath Kundimi, Krishna Chaitanya Kavungala, Swaraj Sinha, Venkata Narasimha Rao Tayi, Nagendra Rao Kundurthi, Trimurtulu Golakoti, Barbara Davis, Krishanu Sengupta. Combined extracts of Moringa oleifera, Murraya koeingii leaves, and Curcuma longa rhizome increases energy expenditure and controls obesity in high-fat diet-fed ratsLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01376-7
269
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo LipogenesisThe American Journal of Pathology 2021;  doi: 10.1016/j.ajpath.2021.05.020
270
Michelle L. Parker, Khosrow Adeli, Émile Lévy, Edgard Delvin. Are universal upper reference limits for alanine aminotransferase (ALT) appropriate for assessing pediatric liver injury?Clinical Biochemistry 2018; 53: 55 doi: 10.1016/j.clinbiochem.2018.01.010
271
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical ApplicationsDiagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
272
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han PopulationJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00010
273
Mark A Anderson, Hamed Kordbacheh, Evita Joseph, Susan E Bennett, Fatima Cody Stanford, Avinash Kambadakone. Computed tomography findings of metabolic syndrome in patients with acute colonic diverticulitisJournal of Medical Imaging and Radiation Oncology 2021; 65(3): 279 doi: 10.1111/1754-9485.13151
274
Nicolás Salva-Pastor, Mayra Domínguez-Pérez, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. Clinical Bioenergetics2021; : 155 doi: 10.1016/B978-0-12-819621-2.00006-1
275
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology2019; : 21 doi: 10.1002/cphy.c190007
276
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
277
Cong Wang, Shousheng Liu, Linlin Lu, Songling Liao, Haiyan Yue, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2018; 18(6) doi: 10.5812/hepatmon.66149